Serum FGF21 levels are increased in chronic HC (CHC) patients with steatosis and are associated with the steatosis grade, which may be a useful diagnostic marker for determining hepatic steatosis in CHC (76). This evidence concerns the gene FGF21 and cryohydrocytosis.